CRH inhibits NF-kappa B signaling in human melanocytes

Peptides. 2006 Dec;27(12):3276-83. doi: 10.1016/j.peptides.2006.07.017. Epub 2006 Sep 7.

Abstract

Corticotropin releasing hormone (CRH), a messenger of stress at the central level, is expressed in the epidermis where it operates within local equivalent of hypothalamo-pituitary axis. CRH inhibits NF-kappaB activity in human immortalized epidermal (PIG1) melanocytes. In melanocytes CRH stimulates pro-opiomelanocortin (POMC) mRNA and adrenocorticotropin (ACTH) peptide production. Knockdown of POMC levels by transfecting cells with antisense oligonucleotides blocks the effect of CRH on NF-kappaB signaling indicating that the above inhibition is indirect, e.g. through activation of POMC. We suggest that induction of POMC by CRH serves as a feedback mechanism to self-restrict inflammatory response in the skin.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Transformed
  • Corticotropin-Releasing Hormone / physiology*
  • Humans
  • Melanocytes / metabolism*
  • NF-kappa B / antagonists & inhibitors*
  • Signal Transduction / physiology*

Substances

  • NF-kappa B
  • Corticotropin-Releasing Hormone